Vivace Therapeutics is developing innovative cancer therapies with the goal of helping patients live longer, healthier lives
Vivace Therapeutics is developing innovative cancer therapies with the goal of helping patients live longer, healthier lives. Their lead program, VT3989, is being evaluated as a potential new treatment for people with advanced mesothelioma, targeting the YAP/TEAD pathway to inhibit tumor growth.